Pain Patches Market Share

  • Report ID: 5783
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT

Pain Patches Industry-Regional Synopsis

North America Market Statistics

By 2037, North America region is projected to hold more than 32% pain patches market share. As per the Centers for Disease Control and Prevention; in 2015, approximately 213 million Americans aged 6 or more participated in sports & fitness activities.  With the rising number of people participating in sport-related activities, a significant number of people deal with injuries and thus require pain relief treatment. Pain patches are being considered as the most preferred option for the same.

APAC Market Analysis

During the projected period, the market for pain patches is expected to have significant expansion in the APAC region as well. The population is aging more quickly in the WHO South-East Asia Region. 9.8% of the population in 2017 is 60 years of age or more, by 2030 and 2050, this percentage will increase to 13.7% and 20.3%, respectively. By 2040, the elderly population in China is predicted to account for 28% of the country's total population due to declining birth rates and increased life expectancy. Elderly persons frequently have problems that cause chronic pain because they are more susceptible to a variety of ailments. Because of this, older consumers have a greater need for treatments resulting to the rise in pain patches market in the Asia-Pacific area.

Pain Patches Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Pain Patches Market in 2025 is evaluated at USD 5.6 billion.

The global market size crossed USD 5.39 billion in 2024 and is likely to register a CAGR of over 4.9%, exceeding USD 10.04 billion revenue by 2037.

North America is estimated to record USD 3.21 billion by 2037, driven by rising number of people participating in sports and fitness activities, leading to an increased demand for pain relief treatments.

The major players in the market include Endo, Inc., Johnson and Johnson Private Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals LLC, Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Grunenthal GmbH, NEXGEL, Inc., Viatris Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos